Transcriptomic assays such as the PAM50-based ROR-P score guide recurrence risk stratification in non-metastatic, ER-positive, HER2-negative breast cancer but are not universally accessible.

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic ...

A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health ...

Accurate defect prediction is essential for better software quality to avoid cost overruns, schedule delays, and reduced system reliability due to software defects. This study presents a Transformer ...

PsyMetRiC is the first validated cardiometabolic prediction tool specifically tailored for this group, developed into a healthcare professional-facing web application PsyMetRiC predicts risks of ...